Traditional cures-maker Bohai ready for liftoff as China expands healthcare

Traditional Chinese medicine maker Bohai Pharmaceuticals has been grabbing headlines lately as well as the interest of investors. The company added five products to its offerings this month: three prescription drugs and two OTC medicines. Investor interest is piqued by ambitious Chinese government healthcare reforms that aim to make such drugs affordable to the rural poor--the majority of China's population. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.